TP53 and cancer: For instance, p53 mutants were found to hamper the activation of caspase-8 [77] and caspase-9 [78], and inhibit the cleavage of caspase-3 [79] through directly binding to these proteins, leading to reduced apoptosis and cancer cell survival and proliferation.